Rob Draper for Precision IO
Ref

Sources.

Every number on this site comes from a public source, listed here by the page that uses it. Company figures are company reported. Analyst market sizes vary widely and are shown as ranges. Scores, targets and hypotheses are mine.

01
02
IJROBP via INCa: 2,313 US radiation therapy facilities (2020)
Becker's ASC on AAMC data: active physicians by specialty
Kothary et al, Stanford 2009: complications of percutaneous fiducial placement for stereotactic radiation
Muacevic et al, JVIR 2014: 222 CT guided fiducial placements for CyberKnife
Auer et al, Radiology 2024: CT guided HDR brachytherapy versus TACE in liver cancer
Frontiers in Oncology 2022: review of interstitial HDR brachytherapy of the liver
LMU Munich: interstitial HDR brachytherapy and SBRT liver dose
Popescu et al, J Contemp Brachytherapy 2015: next generation robotic brachytherapy systems
J Contemp Brachytherapy: dose uncertainty from needle tip error in prostate seed implants
J Contemp Brachytherapy: robot assisted template for CT guided seed implants
Robot assisted seed template accuracy in phantom and animal studies
RSNA: thermal ablation and SBRT, similar survival in stage I lung cancer (NCDB)
ASCO Post: SABR COMET long term results (JCO 2020)
CURE on Xi et al, JCO 2023: SBRT versus RFA for recurrent small HCC
AuntMinnie: salvage thermal ablation after SBRT failure (AJR)
UroToday on Hankins et al: rectal spacer adoption in Medicare (2026)
Elbanna et al, J Contemp Brachytherapy 2025: interstitial brachytherapy use
Brigham and Women's: NIH grant for robot assisted brachytherapy catheter placement
ASTRO survey: Medicare payment pressure on radiation oncology
Siemens Healthineers (Varian): interventional oncology portfolio
DOTmed: Varian acquires Endocare and Alicon (2019)
American Cancer Society: prostate cancer key statistics 2026
NCI SEER: prostate cancer stat facts
ASTRO 2025: Medicare LDR and HDR prostate brachytherapy utilization
Martin et al: The rise and fall of prostate brachytherapy
NCDB: brachytherapy monotherapy trends 2004 to 2014
Urology Times on JAMA 2026: US focal therapy use
EDAP: 2025 results and HIFU revenue
Profound Medical: 2025 results and TULSA installed base
Jamaluddin et al: seed misplacement in prostate brachytherapy
Pubic arch interference in prostate brachytherapy (2022)
JVIR 2023: CT guided cryoablation of recurrent prostate cancer
Biobot iSR'obot Mona Lisa 2.0 FDA clearance
Fichtinger et al: robotic prostate brachytherapy, phase I
AngioDynamics: NanoKnife prostate clearance (Dec 2024)
BCBS Illinois: focal prostate therapy policy (2026)
AUA: renal mass guideline update
MassDevice: Intuitive Ion clearances (2025)
03
04
05